Latest News

How Does the Shift to Early-Stage M&A Change Due Diligence?
How Does the Shift to Early-Stage M&A Change Due Diligence?

May 12th 2025

A well-defined scientific and strategic approach is critical for buyers in this dealmaking setting.

Bridging the Gap:  A Large Pharma Blueprint
Bridging the Gap: A Large Pharma Blueprint

May 9th 2025

Asembia 2025: What Pharma Leaders Must Know About Tariffs, Supply Chains, and Policy Changes
Asembia 2025: What Pharma Leaders Must Know About Tariffs, Supply Chains, and Policy Changes

May 1st 2025

Novartis to Invest $23 Billion in US Manufacturing and R&D Over Five Years
Novartis to Invest $23 Billion in US Manufacturing and R&D Over Five Years

April 11th 2025

Pharmaceutical Industry Avoids Trump’s Tariffs — For Now
Pharmaceutical Industry Avoids Trump’s Tariffs — For Now

April 4th 2025

Video Interviews

More News